Literature DB >> 33145681

A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference.

William C Becker1,2, Erin E Krebs3,4, Sara N Edmond5,6, Lewei A Lin7,8, Mark D Sullivan9, Roger D Weiss10,11, Adam J Gordon12,13.   

Abstract

US military Veterans have been disproportionately impacted by the US opioid overdose crisis. In the fall of 2019, the Veterans Health Administration (VHA) convened a state-of-the-art (SOTA) conference to develop research priorities for advancing the science and clinical practice of opioid safety, including both use of opioid analgesics and managing opioid use disorder. We present the methods and consensus recommendations from the SOTA. A core group of researchers and VA clinical stakeholders defined three areas of focus for the SOTA: managing opioid use disorder, long-term opioid therapy for pain including consideration for opioid tapering, and treatment of co-occurring pain and substance use disorders. The SOTA participants divided into three workgroups and identified key questions and seminal studies related to those three areas of focus. The strongest recommendations included testing implementation strategies in the VHA for expanding access to medication treatment for opioid use disorder, testing collaborative tapering programs for patients prescribed long-term opioids, and larger trials of behavioral and exercise/movement interventions for pain among patients with substance use disorders.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33145681      PMCID: PMC7728950          DOI: 10.1007/s11606-020-06260-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  40 in total

1.  Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.

Authors:  Mark Bounthavong; Michael A Harvey; Daina L Wells; Sarah J Popish; Julianne Himstreet; Elizabeth M Oliva; Chad L Kay; Marcos K Lau; Priyanka P Randeria-Noor; Andrea G Phillips; Melissa L D Christopher
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-11

2.  A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.

Authors:  Lisa A Uebelacker; Donnell Van Noppen; Geoffrey Tremont; Genie Bailey; Ana Abrantes; Michael Stein
Journal:  J Subst Abuse Treat       Date:  2019-07-24

3.  Turning the tide or riptide? The changing opioid epidemic.

Authors:  Stefan G Kertesz
Journal:  Subst Abus       Date:  2016-11-18       Impact factor: 3.716

4.  Emergency department-based peer support for opioid use disorder: Emergent functions and forms.

Authors:  Alan B McGuire; Kristen Gilmore Powell; Peter C Treitler; Karla D Wagner; Krysti P Smith; Nina Cooperman; Lisa Robinson; Jessica Carter; Bradley Ray; Dennis P Watson
Journal:  J Subst Abuse Treat       Date:  2019-06-19

5.  A randomized trial of a pain management intervention for adults receiving substance use disorder treatment.

Authors:  Mark A Ilgen; Amy S B Bohnert; Stephen Chermack; Carly Conran; Mary Jannausch; Jodie Trafton; Frederic C Blow
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

6.  Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.

Authors:  Elizabeth M Oliva; Melissa L D Christopher; Daina Wells; Mark Bounthavong; Michael Harvey; Julianne Himstreet; Thomas Emmendorfer; Michael Valentino; Mariano Franchi; Francine Goodman; Jodie A Trafton
Journal:  J Am Pharm Assoc (2003)       Date:  2017 Mar - Apr

Review 7.  Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.

Authors:  Brandon S Bentzley; Kelly S Barth; Sudie E Back; Sarah W Book
Journal:  J Subst Abuse Treat       Date:  2014-12-30

8.  Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.

Authors:  Bradley D Stein; Mark Sorbero; Andrew W Dick; Rosalie Liccardo Pacula; Rachel M Burns; Adam J Gordon
Journal:  JAMA       Date:  2016-09-20       Impact factor: 56.272

Review 9.  Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.

Authors:  Joseph W Frank; Travis I Lovejoy; William C Becker; Benjamin J Morasco; Christopher J Koenig; Lilian Hoffecker; Hannah R Dischinger; Steven K Dobscha; Erin E Krebs
Journal:  Ann Intern Med       Date:  2017-07-11       Impact factor: 25.391

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  3 in total

1.  Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes.

Authors:  Hannah Cheng; Mark P McGovern; Hélène Chokron Garneau; Brian Hurley; Tammy Fisher; Meaghan Copeland; Daniel Almirall
Journal:  Implement Sci Commun       Date:  2022-07-06

2.  Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.

Authors:  Eric J Hawkins; Carol A Malte; Adam J Gordon; Emily C Williams; Hildi J Hagedorn; Karen Drexler; Brittany E Blanchard; Jennifer L Burden; Jennifer Knoeppel; Anissa N Danner; Aline Lott; Joseph G Liberto; Andrew J Saxon
Journal:  JAMA Netw Open       Date:  2021-12-01

3.  Classification of Patients for Whom Benefit of Long-term Opioid Therapy No Longer Outweighs Harm: Protocol for a Delphi Study.

Authors:  Raymond Van Cleve; Sara Edmond; Jennifer Snow; Anne C Black; Jamie L Pomeranz; William Becker
Journal:  JMIR Res Protoc       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.